0000-0002-4553-2196 About
I am a T-cell biologist working in the area of immunotherapy of chronic metabolic disorders and cancer. My research focuses on engineering microbes, including indole-producing bacteria and Lactobacillus strains, to modulate immune responses. I also study the role of eEF2K and mTOR signaling in CD8+ T cells to enhance anti-tumor immunity. By combining synthetic biology and immunotherapy, I aim to develop innovative treatments for cancer, autoimmune disorders, and metabolic diseases like Type-2 diabetes.
Employment
-
Shiv Nadar University2024 - Present
-
Texas A&M University Postdoc2017 - 2024
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (35)
- Modular Platform for Efficient Assembly of Multifunctional Antibodies Using Orthogonal Protein–Protein Interactions Save
- Metabolic fitness of NAC1-deficient Tregs in the tumor microenvironment fuels tumor growth Save
- eEF2K promotes immune evasion in melanoma via Cyclin D1–mediated stabilization of PD-L1 Save
- Control of CD4+ T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase Save
- Engineered live attenuated bacteria producing 5-hydroxyindole remodels heterogeneous tumor microenvironment and promotes antitumor immunity Save
- T Cell Response to SARS-CoV-2 Coinfection and Comorbidities Save
- Engineering live attenuated vaccines: Old dogs learning new tricks Save
- Expression of NAC1 Restrains the Memory Formation of CD8+ T Cells during Viral Infection Save
- Designer Microbes: Oncotherapy Approach Save
- Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment. Save